Table 1 Clinical cohort.
From: Microbial butyrate capacity is reduced in inflamed mucosa in patients with ulcerative colitis
Total Cohort | ||
|---|---|---|
n | 15 | |
Age, mean (SD) | 40 (14) | |
Gender, female, frequency | 6 (40%) | |
Disease extent, n, (%) | E1 | 0 |
E2 | 0 | |
E3 | 15 (100%) | |
Disease duration, years, median (IQR) | 14 (7.5–18.5) | |
Rectal bleeding score, median (IQR) | 0 (0–1.5) | |
Stool frequency score, mean (SD) | 2 (1–2) | |
Endoscopic activity | 8 (53.3%) | |
Endo-histologic activity | 8 (53.3%) | |
Fiber intake score | 5 (4–7.25) | |
Immunosuppressive exposure, frequency (%) | 11 (73.3%) | |
Concurrent steroid use | 4 (26.7%) | |
Concurrent antibiotic use | 0 | |
Concurrent probiotic use | 0 | |
